Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 86-94

  Kanno, Hiroyuki ^a   Yasunaga, Yutaka ^a   Ohsawa, Masahiko ^a   Taniwaki, Masafumi ^b   Tuchi, Keiji ^c   Naka, Norifumi ^a   Torikai, Kei ^a   Shimoyama, Masanori ^d   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c National Kinki Central Hospital   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; VIRUS DNA;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CANCER GROWTH; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; LYMPHOMA; ONCOGENE C MYC; PLEURA EMPYEMA; PRIORITY JOURNAL; PROTO ONCOGENE; VIRUS GENE;

AGED; ANTIGENS, VIRAL; BASE SEQUENCE; CHROMOSOME ABERRATIONS; DNA-BINDING PROTEINS; EMPYEMA, PLEURAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MOLECULAR SEQUENCE DATA; ONCOGENES; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0030018938     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<86::AID-IJC15>3.0.CO;2-A     Document Type: Article

References (23)

1. BATTEYJ., MOULDING, C., TAUB, R., MURPHY, W., STEWART, T., POTTER, H., LENOIR, G. and LEDER, P., The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell, 34, 779-787 (1983).
2. BOOSH., BERGER, R., KUKLIK-ROOS, C., IFTNER, T. and MUELLER-LANTZSCH, N., Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology, 159, 161-165 (1987).
3. DAMBAUGHT., HENNESSY, K., CHAMNANKIT, L. and KIEFF, E., U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. nat. Acad. Sci. (Wash.), 81, 7632-7636 (1984).
4. FENNEWALDS., VAN SANTEN, V. and KIEFF, E., Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol., 51, 411-419 (1984).
5. FUKAYAMAM., IBUKA, T., HAYASHI, Y., OOBA, T., KOIKE, M. and MIZUTANI, S., Epstein-Barr virus in pyothorax-associated pleural lymphoma. Amer. J. Pathol., 143, 1044-1049 (1993).
6. GAIDANOG. and DALLA-FAVERAR., Biologic and molecular characterization of non-Hodgkin's lymphoma. Curr. Opin. Oncol., 5, 776-784 (1993).
7. HENDERSONS., ROWE, M., GREGORY, C., CROOM-CARTER, D., WANG, F., LONGNECKER, R., KIEFF, E. and RICKINSON, A., Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115 (1991).
8. ISCN (1991), Guidelines for cancer cytogenetics. In: F. Mitelman (ed.), Supplement to an international system for human cytogenetics nomenclature. S. Karger, Basel (1991).
9. IUCHIK., AOZASA, K., YAMAMOTO, S., MORI, T., TAJIMA, K., MINATO, K., MUKAI, K., KOMATSU, H., TAGAKI, T., KOBASHI, Y., YAMABE, H. and SHIMOYAMA, M., Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn. J. clin. Oncol., 19, 249-257 (1989).
10. KANNOH., WOLFINBARGER, J.B. and BLOOM, M.E., Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J. Virol., 67, 2075-2082 (1993).
11. KNUTSONJ.C., The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. J. Virol., 64, 2530-2536 (1990).
12. ε genes. Proc. nat. Acad. Sci. (Wash.), 79, 3833-3837 (1982).
13. RAAB-TRAUBN. and FLYNNK., The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell, 47, 883-889 (1986).
14. RICKINSONA.B., MURRAY, R.J., BROOKS, J., GRIFFIN, H., Moss, D.J. and MASUCCI, M.G., T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv., 13, 53-80 (1992).
15. RICKINSONA.B., YOUNG, L.S. and ROWE, M., Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol., 61, 1310-1317 (1987).
16. SAMPLEJ., HUMMEL, M., BRAUN, D., BIRKENBACH, M. and KIEFF, E., Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc. nat. Acad. Sci. (Wash.), 83, 5096-5100 (1986).
17. SIXBEYJ.W., SHIRLEY, P., CHESNEY, P.J., BUNTIN, D.M. and RESNICK, L., Detection of a second widespread strain of Epstein-Barr virus. Lancet, 761-765 (1989).
18. TANIWAKIM., MATSUDA, F., JAUCH, A., NISHIDA, K., TAKASHIMA, T., TAGAWA, S., SUGIYAMA, H., MISAWA, S., ABE, T. and KASHIMA, K., Detection of 14q32 translocations in B-cell malignancies by in situ hybridization with yeast artificial chromosome clones containing the human IgH gene locus. Blood, 83, 2962-2969 (1994).
19. TRONICKS.R., POPESCU, N.C., CHEAH, M.S.C., SWAN, D.C., AMSBAUGH, S.C., LENGEL, C.R., DIPAOLO, J.A. and ROBBINS, K.C., Isolation and chromosomal localization of the human fgr protooncogene, a distinct member of the tyrosine kinase gene family. Proc. nat. Acad. Sci. (Wash.), 82, 6595-6599 (1985).
20. TSUJIMOTOY. and CROCEC.M., Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. nat. Acad. Sci. (Wash.), 83, 5214-5218 (1986).
21. WANGF., TSANG, S.-F., KURILLA, M.G., COHEN, J.I. and KIEFF, E., Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol., 64, 3407-3416 (1990).
22. WENNBORGA., AMAN, P., SARANATH, D., PEAR, W., SUMEGI, J. and KLEIN, G., Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels. Int. J. Cancer, 40, 202-206 (1987).
23. WOLFH., BOGEDAIN, C. and SCHWARZMANN, F., Epstein-Barr virus and its interaction with the host. Intervirology, 35, 26-39 (1993).